{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T00:25:55Z","timestamp":1777681555576,"version":"3.51.4"},"reference-count":23,"publisher":"SAGE Publications","issue":"6","license":[{"start":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T00:00:00Z","timestamp":1684540800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Hosp Pharm"],"published-print":{"date-parts":[[2023,12]]},"abstract":"<jats:p>Background and objective: Hospital acquired venous thromboembolisms (VTEs) are common and preventable. The Queensland Health VTE prophylaxis guidelines, developed in 2018, provide guidance for risk assessment, and prescribing of anticoagulation for prophylaxis and treatment of hospital inpatients. Currently, there are limited recommendations for gastroenterology patients. This study investigated the completion of VTE risk assessments, and the appropriateness of VTE prophylaxis regimens, in accordance with Queensland Health guidelines for gastroenterology patients. The quality and safety of VTE prophylaxis regimens was assessed based on their VTE risk and bleeding risk. Method: A retrospective study was conducted by obtaining a random sample of gastroenterology patients admitted to a tertiary Australian hospital, from 1st May 2019 and 1st May 2020, to determine the compliance of VTE risk assessment and thromboprophylaxis prescribing with state-wide VTE guidelines. The quality and safety of thromboprophylaxis was evaluated using the modified Caprini and HASBLED scores, and subsequent thromboprophylaxis-related complications. Results: Of the 94 patients reviewed, 68 did not have contraindications to thromboprophylaxis. Of these 68 patients, 32 (47%) had no VTE risk assessment recorded in their clinical records and were not prescribed any thromboprophylaxis during the hospitalization. There was no significant difference between thromboprophylaxis prescribing for patients with low VTE risk, compared to moderate to high VTE risk ( P\u2009=\u2009.075). There was a trend for decrease in thromboprophylaxis prescribing as HASBLED bleeding risk score increased, and patients with moderate-high bleed risk were less likely to be prescribed thromboprophylaxis ( P\u2009=\u2009.006). There were no thromboprophylaxis related complications identified. Conclusion: It is essential that all patients have a clearly documented risk assessment and are prescribed thromboprophylaxis according to best practice guidelines. The prescription of venous thromboembolism prophylaxis should continue to be individualized, with each patient assessed holistically.<\/jats:p>","DOI":"10.1177\/00185787231172385","type":"journal-article","created":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T05:14:02Z","timestamp":1684559642000},"page":"595-604","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":0,"title":["Evaluation of the Quality and Safety of Venous Thromboembolism Prophylaxis Among Gastroenterology Inpatients at a Tertiary Hospital in Australia"],"prefix":"10.1177","volume":"58","author":[{"given":"Nameer","family":"van Oosterom","sequence":"first","affiliation":[{"name":"University of Queensland, Brisbane, QLD, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6708-2691","authenticated-orcid":false,"given":"Keshia R.","family":"De Guzman","sequence":"additional","affiliation":[{"name":"University of Queensland, Brisbane, QLD, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7640-1471","authenticated-orcid":false,"given":"Karl","family":"Winckel","sequence":"additional","affiliation":[{"name":"University of Queensland, Brisbane, QLD, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anissa","family":"Johnson","sequence":"additional","affiliation":[{"name":"University of Queensland, Brisbane, QLD, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nazanin","family":"Falconer","sequence":"additional","affiliation":[{"name":"University of Queensland, Brisbane, QLD, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2023,5,20]]},"reference":[{"key":"bibr1-00185787231172385","unstructured":"Government. A. Hospital-Aquired Complication 7 \u2013 Venous Thromboembolism. In: Care ACoSaQiH, ed. 2018."},{"key":"bibr2-00185787231172385","unstructured":"Australian Commission on Safety and Quality in Health Care. Selected best practices and suggestions for improvement for clinicians Hospital-Acquired Complication Venous Thromboembolism. 2018. Accessed September 7, 2018. https:\/\/www.safetyandquality.gov.au\/publications-and-resources\/resource-library\/venous-thromboembolism-prevention-clinical-care-standard-clinician-fact-sheet"},{"key":"bibr3-00185787231172385","unstructured":"National Institute for Health and Care Excellence (NICE). Venous thromboembolism in over 16s: reducing the risk of hospital-aquired deep vein thrombosis or pulmonary embolism. 2018. Accessed September 7, 2018. https:\/\/www.nice.org.uk\/guidance\/ng89."},{"key":"bibr4-00185787231172385","unstructured":"Scottish Intercollegiate Guidelines Network (SIGN). Prevention and Management of Venous Thromboembolism Edinburgh: SIGN. 2010 (updated 2014) [publication no. 122]. https:\/\/www.sign.ac.uk\/our-guidelines\/prevention-and-management-of-venous-thromboembolism\/ Accessed September 7, 2018."},{"key":"bibr5-00185787231172385","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2015.11.026"},{"key":"bibr6-00185787231172385","doi-asserted-by":"publisher","DOI":"10.5694\/j.1326-5377.2008.tb01943.x"},{"key":"bibr7-00185787231172385","unstructured":"State of Queensland (Queensland Health). Prevention of Venous Thromboembolism (VTE) in Adult Hospitalised Patients \u2013 Guideline Overview. 2018. https:\/\/www.health.qld.gov.au\/__data\/assets\/pdf_file\/0029\/812936\/flowchart-vte-prevention-guideline.pdf Accessed September 7, 2018."},{"key":"bibr8-00185787231172385","unstructured":"State of Queensland (Queensland Health). Guideline for the prevention of Venous Thromboembolism (VTE) in adult hospitalised patients. 2018. https:\/\/www.health.qld.gov.au\/\u2013data\/assets\/pdf_file\/0031\/812938\/vte-prevention-guideline.pdf Accessed September 7, 2018."},{"key":"bibr9-00185787231172385","doi-asserted-by":"publisher","DOI":"10.1016\/j.disamonth.2018.12.005"},{"key":"bibr10-00185787231172385","doi-asserted-by":"publisher","DOI":"10.1378\/chest.10-0134"},{"key":"bibr11-00185787231172385","doi-asserted-by":"publisher","DOI":"10.1053\/j.jvca.2019.01.021"},{"key":"bibr12-00185787231172385","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2015-010471"},{"key":"bibr13-00185787231172385","unstructured":"eTG Complete. Venous Thromboembolism: Prophylaxis. 2018. Accessed September 14, 2018. https:\/\/tgldcdp-tg-org-au.ezproxy.library.uq.edu.au\/viewTopic?topicfile=venous-thromboembolism-prevention&guidelineName=Cardiovascular#toc_d1e472020"},{"key":"bibr14-00185787231172385","doi-asserted-by":"publisher","DOI":"10.1007\/s11239-019-01847-4"},{"key":"bibr15-00185787231172385","doi-asserted-by":"publisher","DOI":"10.1111\/jth.13140"},{"key":"bibr16-00185787231172385","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2018024489"},{"key":"bibr17-00185787231172385","doi-asserted-by":"publisher","DOI":"10.1186\/1472-6963-11-240"},{"key":"bibr18-00185787231172385","doi-asserted-by":"publisher","DOI":"10.1136\/bmjoq-2017-000171"},{"key":"bibr19-00185787231172385","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijmedinf.2014.10.001"},{"key":"bibr20-00185787231172385","first-page":"98","volume":"225","author":"Clarke S","year":"2016","journal-title":"Stud Health Technol Inform"},{"key":"bibr21-00185787231172385","unstructured":"Zhuang M, Concannon D, Manley E. A Framework for Evaluating Dashboards in Healthcare. 2020. Accessed September 14, 2018. https:\/\/arxiv.org\/pdf\/2009.04792.pdf"},{"key":"bibr22-00185787231172385","doi-asserted-by":"publisher","DOI":"10.2146\/ajhp160556"},{"key":"bibr23-00185787231172385","doi-asserted-by":"publisher","DOI":"10.1177\/0897190013514091"}],"container-title":["Hospital Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/00185787231172385","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/00185787231172385","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/00185787231172385","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T08:40:16Z","timestamp":1777452016000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/00185787231172385"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,20]]},"references-count":23,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["10.1177\/00185787231172385"],"URL":"https:\/\/doi.org\/10.1177\/00185787231172385","relation":{},"ISSN":["0018-5787","1945-1253"],"issn-type":[{"value":"0018-5787","type":"print"},{"value":"1945-1253","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,20]]}}}